Page last updated: 2024-11-06

benzimidazole and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

benzimidazole has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 2 studies

1H-benzimidazole : The 1H-tautomer of benzimidazole.

Research Excerpts

ExcerptRelevanceReference
"Crystal structure analysis revealed key interactions of a 2-amino-benzimidazole viral translation inhibitor that captures an elongated conformation of an RNA switch target in the internal ribosome entry site (IRES) of hepatitis C virus (HCV)."3.83Ligand Optimization by Improving Shape Complementarity at a Hepatitis C Virus RNA Target. ( Boerneke, MA; Charrette, BP; Hermann, T, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Charrette, BP1
Boerneke, MA1
Hermann, T1
Randolph, JT1
Flentge, CA1
Donner, P1
Rockway, TW1
Patel, SV1
Nelson, L1
Hutchinson, DK1
Mondal, R1
Mistry, N1
Reisch, T1
Dekhtyar, T1
Krishnan, P1
Pilot-Matias, T1
Stolarik, DF1
Beno, DWA1
Wagner, R1
Maring, C1
Kati, WM1

Other Studies

2 other studies available for benzimidazole and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

ArticleYear
Ligand Optimization by Improving Shape Complementarity at a Hepatitis C Virus RNA Target.
    ACS chemical biology, 2016, 12-16, Volume: 11, Issue:12

    Topics: Antiviral Agents; Benzimidazoles; Drug Design; Hepacivirus; Hepatitis C; Humans; Internal Ribosome E

2016
Discovery of fluorobenzimidazole HCV NS5A inhibitors.
    Bioorganic & medicinal chemistry letters, 2016, 11-15, Volume: 26, Issue:22

    Topics: Animals; Antiviral Agents; Benzimidazoles; Dogs; Genotype; Halogenation; Hepacivirus; Hepatitis C; H

2016